Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA) and maintenance of normal (fasting) blood concentrations of triglycerides (ID 533, 691, 3150), protection of blood lipids from oxidative damage (ID 630), contribution to the maintenance or achievement of a normal body weight (ID 629), brain, eye and nerve development (ID 627, 689, 704, 742, 3148, 3151), maintenance of normal brain function (ID 565, 626, 631, 689, 690, 704, 742, 3148, 3151), maintenance of normal vision (ID 627, 632, 743, 3149) and maintenance of normal spermatozoa motility (ID 628) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-1320, EFSA-Q-2008-1416, EFSA-Q-2008-1417, EFSA-Q-2008-1478, EFSA-Q-2008-3882 , EFSA-Q-2008-1352, EFSA-Q-2008-1413, EFSA-Q-2008-1414, EFSA-Q-2008-1415, EFSA-Q-2008-1418, EFSA-Q-2008-1419, EFSA-Q-2008-1476, EFSA-Q-2008-1477, EFSA-Q-2008-1491, EFSA-Q-2008-1529, EFSA-Q-2008-1530, EFSA-Q-2008-3880, EFSA-Q-2008-3881, EFSA-Q-2008-3883

Inge Tetens

Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA) and maintenance of normal (fasting) blood concentrations of triglycerides (ID 533, 691, 3150), protection of blood lipids from oxidative damage (ID 630), contribution to the maintenance or achievement of a normal body weight (ID 629), brain, eye and nerve development (ID 627, 689, 704, 742, 3148, 3151), maintenance of normal brain function (ID 565, 626, 631, 689, 690, 704, 742, 3148, 3151), maintenance of normal vision (ID 627, 632, 743, 3149) and maintenance of normal spermatozoa motility (ID 628) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-1320, EFSA-Q-2008-1416, EFSA-Q-2008-1417, EFSA-Q-2008-1478, EFSA-Q-2008-3882 , EFSA-Q-2008-1352, EFSA-Q-2008-1413, EFSA-Q-2008-1414, EFSA-Q-2008-1415, EFSA-Q-2008-1418, EFSA-Q-2008-1419, EFSA-Q-2008-1476, EFSA-Q-2008-1477, EFSA-Q-2008-1491, EFSA-Q-2008-1529, EFSA-Q-2008-1530, EFSA-Q-2008-3880, EFSA-Q-2008-3881, EFSA-Q-2008-3883

Inge Tetens

National Food Institute

Research output: Book/Report › Report › peer-review

Original language	English

Publisher	European Food Safety Authority
Publication status	Published - 2010

Keywords

spermatozoa motility
Docosahexaenoic acid
brain function
vision
weight management
health claims
blood lipids
oxidative damage
DHA

Cite this

Tetens, I. (2010). Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA) and maintenance of normal (fasting) blood concentrations of triglycerides (ID 533, 691, 3150), protection of blood lipids from oxidative damage (ID 630), contribution to the maintenance or achievement of a normal body weight (ID 629), brain, eye and nerve development (ID 627, 689, 704, 742, 3148, 3151), maintenance of normal brain function (ID 565, 626, 631, 689, 690, 704, 742, 3148, 3151), maintenance of normal vision (ID 627, 632, 743, 3149) and maintenance of normal spermatozoa motility (ID 628) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-1320, EFSA-Q-2008-1416, EFSA-Q-2008-1417, EFSA-Q-2008-1478, EFSA-Q-2008-3882 , EFSA-Q-2008-1352, EFSA-Q-2008-1413, EFSA-Q-2008-1414, EFSA-Q-2008-1415, EFSA-Q-2008-1418, EFSA-Q-2008-1419, EFSA-Q-2008-1476, EFSA-Q-2008-1477, EFSA-Q-2008-1491, EFSA-Q-2008-1529, EFSA-Q-2008-1530, EFSA-Q-2008-3880, EFSA-Q-2008-3881, EFSA-Q-2008-3883. European Food Safety Authority.

Tetens, Inge. / Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA) and maintenance of normal (fasting) blood concentrations of triglycerides (ID 533, 691, 3150), protection of blood lipids from oxidative damage (ID 630), contribution to the maintenance or achievement of a normal body weight (ID 629), brain, eye and nerve development (ID 627, 689, 704, 742, 3148, 3151), maintenance of normal brain function (ID 565, 626, 631, 689, 690, 704, 742, 3148, 3151), maintenance of normal vision (ID 627, 632, 743, 3149) and maintenance of normal spermatozoa motility (ID 628) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 : EFSA-Q-2008-1320, EFSA-Q-2008-1416, EFSA-Q-2008-1417, EFSA-Q-2008-1478, EFSA-Q-2008-3882 , EFSA-Q-2008-1352, EFSA-Q-2008-1413, EFSA-Q-2008-1414, EFSA-Q-2008-1415, EFSA-Q-2008-1418, EFSA-Q-2008-1419, EFSA-Q-2008-1476, EFSA-Q-2008-1477, EFSA-Q-2008-1491, EFSA-Q-2008-1529, EFSA-Q-2008-1530, EFSA-Q-2008-3880, EFSA-Q-2008-3881, EFSA-Q-2008-3883. European Food Safety Authority, 2010.

@book{8d4348ac5c3c43589882302a67539118,

title = "Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA) and maintenance of normal (fasting) blood concentrations of triglycerides (ID 533, 691, 3150), protection of blood lipids from oxidative damage (ID 630), contribution to the maintenance or achievement of a normal body weight (ID 629), brain, eye and nerve development (ID 627, 689, 704, 742, 3148, 3151), maintenance of normal brain function (ID 565, 626, 631, 689, 690, 704, 742, 3148, 3151), maintenance of normal vision (ID 627, 632, 743, 3149) and maintenance of normal spermatozoa motility (ID 628) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-1320, EFSA-Q-2008-1416, EFSA-Q-2008-1417, EFSA-Q-2008-1478, EFSA-Q-2008-3882 , EFSA-Q-2008-1352, EFSA-Q-2008-1413, EFSA-Q-2008-1414, EFSA-Q-2008-1415, EFSA-Q-2008-1418, EFSA-Q-2008-1419, EFSA-Q-2008-1476, EFSA-Q-2008-1477, EFSA-Q-2008-1491, EFSA-Q-2008-1529, EFSA-Q-2008-1530, EFSA-Q-2008-3880, EFSA-Q-2008-3881, EFSA-Q-2008-3883",

keywords = "spermatozoa motility, Docosahexaenoic acid, brain function, vision, weight management, health claims, blood lipids, oxidative damage, DHA",

author = "Inge Tetens",

year = "2010",

language = "English",

publisher = "European Food Safety Authority",

}

Tetens, I 2010, Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA) and maintenance of normal (fasting) blood concentrations of triglycerides (ID 533, 691, 3150), protection of blood lipids from oxidative damage (ID 630), contribution to the maintenance or achievement of a normal body weight (ID 629), brain, eye and nerve development (ID 627, 689, 704, 742, 3148, 3151), maintenance of normal brain function (ID 565, 626, 631, 689, 690, 704, 742, 3148, 3151), maintenance of normal vision (ID 627, 632, 743, 3149) and maintenance of normal spermatozoa motility (ID 628) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-1320, EFSA-Q-2008-1416, EFSA-Q-2008-1417, EFSA-Q-2008-1478, EFSA-Q-2008-3882 , EFSA-Q-2008-1352, EFSA-Q-2008-1413, EFSA-Q-2008-1414, EFSA-Q-2008-1415, EFSA-Q-2008-1418, EFSA-Q-2008-1419, EFSA-Q-2008-1476, EFSA-Q-2008-1477, EFSA-Q-2008-1491, EFSA-Q-2008-1529, EFSA-Q-2008-1530, EFSA-Q-2008-3880, EFSA-Q-2008-3881, EFSA-Q-2008-3883. European Food Safety Authority.

Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA) and maintenance of normal (fasting) blood concentrations of triglycerides (ID 533, 691, 3150), protection of blood lipids from oxidative damage (ID 630), contribution to the maintenance or achievement of a normal body weight (ID 629), brain, eye and nerve development (ID 627, 689, 704, 742, 3148, 3151), maintenance of normal brain function (ID 565, 626, 631, 689, 690, 704, 742, 3148, 3151), maintenance of normal vision (ID 627, 632, 743, 3149) and maintenance of normal spermatozoa motility (ID 628) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 : EFSA-Q-2008-1320, EFSA-Q-2008-1416, EFSA-Q-2008-1417, EFSA-Q-2008-1478, EFSA-Q-2008-3882 , EFSA-Q-2008-1352, EFSA-Q-2008-1413, EFSA-Q-2008-1414, EFSA-Q-2008-1415, EFSA-Q-2008-1418, EFSA-Q-2008-1419, EFSA-Q-2008-1476, EFSA-Q-2008-1477, EFSA-Q-2008-1491, EFSA-Q-2008-1529, EFSA-Q-2008-1530, EFSA-Q-2008-3880, EFSA-Q-2008-3881, EFSA-Q-2008-3883. / Tetens, Inge.

European Food Safety Authority, 2010.

Research output: Book/Report › Report › peer-review

TY - RPRT

T1 - Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA) and maintenance of normal (fasting) blood concentrations of triglycerides (ID 533, 691, 3150), protection of blood lipids from oxidative damage (ID 630), contribution to the maintenance or achievement of a normal body weight (ID 629), brain, eye and nerve development (ID 627, 689, 704, 742, 3148, 3151), maintenance of normal brain function (ID 565, 626, 631, 689, 690, 704, 742, 3148, 3151), maintenance of normal vision (ID 627, 632, 743, 3149) and maintenance of normal spermatozoa motility (ID 628) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

T2 - EFSA-Q-2008-1320, EFSA-Q-2008-1416, EFSA-Q-2008-1417, EFSA-Q-2008-1478, EFSA-Q-2008-3882 , EFSA-Q-2008-1352, EFSA-Q-2008-1413, EFSA-Q-2008-1414, EFSA-Q-2008-1415, EFSA-Q-2008-1418, EFSA-Q-2008-1419, EFSA-Q-2008-1476, EFSA-Q-2008-1477, EFSA-Q-2008-1491, EFSA-Q-2008-1529, EFSA-Q-2008-1530, EFSA-Q-2008-3880, EFSA-Q-2008-3881, EFSA-Q-2008-3883

AU - Tetens, Inge

PY - 2010

Y1 - 2010

KW - spermatozoa motility

KW - Docosahexaenoic acid

KW - brain function

KW - vision

KW - weight management

KW - health claims

KW - blood lipids

KW - oxidative damage

KW - DHA

M3 - Report

BT - Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA) and maintenance of normal (fasting) blood concentrations of triglycerides (ID 533, 691, 3150), protection of blood lipids from oxidative damage (ID 630), contribution to the maintenance or achievement of a normal body weight (ID 629), brain, eye and nerve development (ID 627, 689, 704, 742, 3148, 3151), maintenance of normal brain function (ID 565, 626, 631, 689, 690, 704, 742, 3148, 3151), maintenance of normal vision (ID 627, 632, 743, 3149) and maintenance of normal spermatozoa motility (ID 628) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

PB - European Food Safety Authority

ER -

Tetens I. Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA) and maintenance of normal (fasting) blood concentrations of triglycerides (ID 533, 691, 3150), protection of blood lipids from oxidative damage (ID 630), contribution to the maintenance or achievement of a normal body weight (ID 629), brain, eye and nerve development (ID 627, 689, 704, 742, 3148, 3151), maintenance of normal brain function (ID 565, 626, 631, 689, 690, 704, 742, 3148, 3151), maintenance of normal vision (ID 627, 632, 743, 3149) and maintenance of normal spermatozoa motility (ID 628) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-1320, EFSA-Q-2008-1416, EFSA-Q-2008-1417, EFSA-Q-2008-1478, EFSA-Q-2008-3882 , EFSA-Q-2008-1352, EFSA-Q-2008-1413, EFSA-Q-2008-1414, EFSA-Q-2008-1415, EFSA-Q-2008-1418, EFSA-Q-2008-1419, EFSA-Q-2008-1476, EFSA-Q-2008-1477, EFSA-Q-2008-1491, EFSA-Q-2008-1529, EFSA-Q-2008-1530, EFSA-Q-2008-3880, EFSA-Q-2008-3881, EFSA-Q-2008-3883. European Food Safety Authority, 2010.